Table 2. Comparison of prevalence of AMI and relevant cardiovascular comorbidities between American and Taiwanese patients with ADPKD.
| American (N = 419)* | Taiwanese (N = 2062) | P-value | |
|---|---|---|---|
| Age | 53.2 ± 13.7 | 47.6 ± 13.6 | |
| Gender | <.0001 | ||
| Female | 64.6% (265/410) | 51.5% | |
| Male | 35.4% (145/410) | 48.5% | |
| Acute myocardial infarction | 6% (24/399) | 2.9% | 0.0567 |
| Comorbidities | |||
| Hypertension | 86.6% (356/411) | 81.1% | 0.0081 |
| Diabetes mellitus | 8.7% (36/412) | 15.0% | 0.0008 |
| Dyslipidemia | 45.7% (188/411) | 34.6% | <.0001 |
| Arrhythmia | 25.9% (103/398) | 19.3% | 0.0028 |
| Heart failure | 9.5% (38/400) | 10.5% | 0.5527 |
| Valvular heart disease | 14.4% (57/397) | 8.5% | 0.0003 |
| Peripheral vascular disease | 16.5% (66/400) | 6.6% | <.0001 |
AMI = acute myocardial infarction, ADPKD = autosomal dominant polycystic kidney disease
*Data was adopted from the publication by Helal et al.[9]